Yuanzeng Min

4.7k total citations · 2 hit papers
61 papers, 4.0k citations indexed

About

Yuanzeng Min is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Yuanzeng Min has authored 61 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Biomedical Engineering and 22 papers in Molecular Biology. Recurrent topics in Yuanzeng Min's work include Nanoplatforms for cancer theranostics (22 papers), Immunotherapy and Immune Responses (16 papers) and Nanoparticle-Based Drug Delivery (12 papers). Yuanzeng Min is often cited by papers focused on Nanoplatforms for cancer theranostics (22 papers), Immunotherapy and Immune Responses (16 papers) and Nanoparticle-Based Drug Delivery (12 papers). Yuanzeng Min collaborates with scholars based in China, United States and Singapore. Yuanzeng Min's co-authors include Andrew Z. Wang, Joseph M. Caster, Michael J. Eblan, Yangzhong Liu, Bengang Xing, Jinming Li, Fang Liu, Ming Da Lee, Chengqiong Mao and Jun Wang and has published in prestigious journals such as Chemical Reviews, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Yuanzeng Min

55 papers receiving 3.9k citations

Hit Papers

Clinical Translation of N... 2015 2026 2018 2022 2015 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Translation of Nanomedicine
    2015 628 citations Yuanzeng Min, Andrew Z. Wang et al. profile →
  2. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
    2017 590 citations Yuanzeng Min, Kyle C. Roche et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanzeng Min China 28 2.0k 1.5k 1.3k 1.1k 826 61 4.0k
Xiao‐Jiao Du China 30 2.7k 1.4× 2.5k 1.7× 1.9k 1.5× 846 0.8× 587 0.7× 67 5.1k
Rutian Li China 35 1.4k 0.7× 1.7k 1.2× 1.4k 1.1× 521 0.5× 656 0.8× 132 3.7k
Kazuko Toh Japan 40 1.8k 0.9× 2.0k 1.4× 2.4k 1.9× 756 0.7× 446 0.5× 70 4.8k
Xiaoding Xu China 42 2.3k 1.2× 1.7k 1.1× 2.9k 2.3× 1.5k 1.4× 388 0.5× 118 6.5k
Weijing Yang China 37 2.5k 1.3× 1.3k 0.9× 1.4k 1.1× 995 0.9× 456 0.6× 69 4.1k
Suresh Gadde United States 36 1.6k 0.8× 1.5k 1.0× 1.4k 1.1× 1.8k 1.7× 454 0.5× 73 5.0k
Wenbing Dai China 46 2.2k 1.1× 2.6k 1.8× 2.3k 1.8× 535 0.5× 801 1.0× 133 5.5k
Xiaopin Duan China 24 3.1k 1.6× 1.5k 1.0× 1.3k 1.0× 1.3k 1.2× 790 1.0× 44 5.0k
Meng Yu China 42 2.6k 1.3× 1.2k 0.8× 1.6k 1.3× 1.6k 1.5× 320 0.4× 100 5.0k
Richard Wooster United States 18 3.0k 1.5× 2.6k 1.8× 2.6k 2.1× 1.0k 0.9× 823 1.0× 29 6.0k

Countries citing papers authored by Yuanzeng Min

Since Specialization
Citations

This map shows the geographic impact of Yuanzeng Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanzeng Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanzeng Min more than expected).

Fields of papers citing papers by Yuanzeng Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanzeng Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanzeng Min. The network helps show where Yuanzeng Min may publish in the future.

Co-authorship network of co-authors of Yuanzeng Min

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanzeng Min. A scholar is included among the top collaborators of Yuanzeng Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanzeng Min. Yuanzeng Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Peijie, Dong Qian, Xin Ming, et al.. (2025). Nanotherapeutic Wee1 Inhibition Sensitizes Tumor Ferroptosis to Promote Cancer Immunotherapy and Abscopal Effect. ACS Nano. 19(17). 16307–16326.
2.
Pan, Wen, et al.. (2024). Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance. Advanced Functional Materials. 34(45). 4 indexed citations
3.
Zhong, Yuan, Zehua Liu, Gang Wang, et al.. (2024). Solar-driven sugar production directly from CO2 via a customizable electrocatalytic–biocatalytic flow system. Nature Communications. 15(1). 2636–2636. 40 indexed citations
4.
Gao, Feng, Aobo Chen, Yangguang Hu, et al.. (2023). Artificial photosynthetic cells with biotic–abiotic hybrid energy modules for customized CO2 conversion. Nature Communications. 14(1). 36 indexed citations
5.
Chen, Bo, Ruijie Huang, Wei Zeng, Wei Wang, & Yuanzeng Min. (2023). Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect. Biomaterials. 305. 122434–122434. 23 indexed citations
6.
Li, Rui, et al.. (2023). Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy. Journal of Medicinal Chemistry. 66(17). 12225–12236. 5 indexed citations
7.
Li, Rui, et al.. (2022). Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy. Acta Biomaterialia. 154. 401–411. 13 indexed citations
8.
Pan, Wen, et al.. (2022). Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy. Acta Biomaterialia. 158. 698–707. 12 indexed citations
9.
Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2021). Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models. Acta Biomaterialia. 124. 327–335. 54 indexed citations
10.
Zheng, Xueying, Sihui Luo, Wei Wang, et al.. (2020). Nanotechnology's application in Type 1 diabetes. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(6). e1645–e1645. 6 indexed citations
11.
Wu, Haibo, et al.. (2020). Immunological Effects of Aggregation-Induced Emission Materials. Frontiers in Immunology. 11. 575816–575816. 10 indexed citations
12.
Zhang, Han, Chengqiong Mao, Yuanzeng Min, et al.. (2018). P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes. ACS Applied Materials & Interfaces. 10(39). 33464–33473. 63 indexed citations
13.
Wan, Xiaomeng, Yuanzeng Min, Herdis Bludau, et al.. (2018). Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer. ACS Nano. 12(3). 2426–2439. 132 indexed citations
14.
Tian, Jing, Yuanzeng Min, Zachary L. Rodgers, et al.. (2017). Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models. Journal of Materials Chemistry B. 5(30). 6049–6057. 48 indexed citations
15.
16.
Min, Yuanzeng, Qinqin Cheng, Hongdong Shi, et al.. (2013). Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II). Journal of Inorganic Biochemistry. 129. 15–22. 11 indexed citations
17.
Min, Yuanzeng, Jinming Li, Fang Liu, Ming Da Lee, & Bengang Xing. (2013). Near‐Infrared Light‐Mediated Photoactivation of a Platinum Antitumor Prodrug and Simultaneous Cellular Apoptosis Imaging by Upconversion‐Luminescent Nanoparticles. Angewandte Chemie. 126(4). 1030–1034. 75 indexed citations
18.
Ni, Jia, Kai‐Ju Wei, Yuanzeng Min, et al.. (2012). Copper(i) coordination polymers of 2,2′-dipyridylamine derivatives: syntheses, structures, and luminescence. Dalton Transactions. 41(17). 5280–5280. 62 indexed citations
19.
20.
Ma, Guolin, Yuanzeng Min, Fan Huang, Tao Jiang, & Yangzhong Liu. (2010). Thioether binding mediates monofunctional platinum antitumor reagents to trans configuration in DNA interactions. Chemical Communications. 46(37). 6938–6938. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao‐Jiao Du Breakdown of academic impact, for papers by Rutian Li Breakdown of academic impact, for papers by Kazuko Toh Breakdown of academic impact, for papers by Xiaoding Xu Breakdown of academic impact, for papers by Weijing Yang Breakdown of academic impact, for papers by Suresh Gadde Breakdown of academic impact, for papers by Wenbing Dai Breakdown of academic impact, for papers by Xiaopin Duan Breakdown of academic impact, for papers by Meng Yu Breakdown of academic impact, for papers by Richard Wooster
Rankless by CCL
2026